Compare SRZN & RAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRZN | RAC |
|---|---|---|
| Founded | 2015 | 2024 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.6M | 307.3M |
| IPO Year | 2020 | 2025 |
| Metric | SRZN | RAC |
|---|---|---|
| Price | $22.42 | $10.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | ★ 255.4K | 21.6K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,477,000.00 | N/A |
| Revenue This Year | $75.35 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $35.57 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.30 | $10.19 |
| 52 Week High | $35.00 | $10.57 |
| Indicator | SRZN | RAC |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 72.36 |
| Support Level | $20.26 | $10.34 |
| Resistance Level | $24.13 | $10.55 |
| Average True Range (ATR) | 1.40 | 0.01 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 8.67 | 79.90 |
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Rithm Acquisition Corp is a blank check company.